Sarissa Capital Management LP Long-Term Concentrated

CIK: 0001577524 · Show all filings

Period: Q1 2015 (← Previous) (Next →)

Filing Date: May 15, 2015

Total Value ($000): $474,075 (100.0% shares, 0.0% debt)

Holdings (17)

— ARIAD PHARMACEUTICALS INC 22.3%

Value ($000) $105,884 Shares 12,850,000 Est. Cost $6.73 Unrealized —

ABBV ABBVIE INC. 19.5%

Value ($000) $92,493 Shares 1,580,000 Est. Cost $38.85 Unrealized 0.0%

DGX QUEST DIAGNOSTICS INC 12.6%

Value ($000) $59,559 Shares 775,000 Est. Cost $46.05 Unrealized +25.1%

AMGN AMGEN INC 10.7%

Value ($000) $50,832 Shares 318,000 Est. Cost $104.63 Unrealized +9.9%

— AEGERION PHARMACEUTICALS INC 9.0%

Value ($000) $42,852 Shares 1,637,455 Est. Cost $26.17 Unrealized —

— MEDICINES CO 7.2%

Value ($000) $34,047 Shares 1,215,100 Est. Cost $28.02 Unrealized —

MRK MERCK & CO INC NEW 4.8%

Value ($000) $22,992 Shares 400,000 Est. Cost $31.29 Unrealized +28.8%

— FLAMEL TECHNOLOGIES SA 3.3%

Value ($000) $15,733 Shares 875,000 Est. Cost $17.98 Unrealized —

— APRICUS BIOSCIENCES INC 2.6%

Value ($000) $12,201 Shares 6,524,505 Est. Cost $1.73 Unrealized —

— REPROS THERAPEUTICS INC 2.1%

Value ($000) $9,727 Shares 1,132,367 Est. Cost $16.90 Unrealized —

— INTRA CELLULAR THERAPIES INC 1.8%

Value ($000) $8,597 Shares 360,000 Est. Cost $16.06 Unrealized —

— VIVUS INC 1.3%

Value ($000) $6,332 Shares 2,573,943 Est. Cost $9.08 Unrealized —

— KINDRED BIOSCIENCES INC 1.0%

Value ($000) $4,920 Shares 689,091 Est. Cost $11.56 Unrealized —

— AVEO PHARMACEUTICALS INC 0.8%

Value ($000) $3,728 Shares 2,570,759 Est. Cost $1.84 Unrealized —

ANIP ANI PHARMACEUTICALS INC 0.4%

Value ($000) $1,939 Shares 31,000 Est. Cost $44.09 Unrealized +38.0%

— TARGACEPT INC 0.4%

Value ($000) $1,871 Shares 630,000 Est. Cost $4.63 Unrealized —

— ELEVEN BIOTHERAPEUTICS INC. 0.1%

Value ($000) $368 Shares 41,200 Est. Cost $11.87 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
—	ARIAD PHARMACEUTICALS INC	12,850,000	$105,884	22.3%	$6.73	—	COM	04033A100
ABBV	ABBVIE INC.	1,580,000	$92,493	19.5%	$38.85	0.0%	COM	00287Y109
DGX	QUEST DIAGNOSTICS INC	775,000	$59,559	12.6%	$46.05	+25.1%	COM	74834L100
AMGN	AMGEN INC	318,000	$50,832	10.7%	$104.63	+9.9%	COM	031162100
—	AEGERION PHARMACEUTICALS INC	1,637,455	$42,852	9.0%	$26.17	—	COM	00767E102
—	MEDICINES CO	1,215,100	$34,047	7.2%	$28.02	—	COM	584688105
MRK	MERCK & CO INC NEW	400,000	$22,992	4.8%	$31.29	+28.8%	COM	58933Y105
—	FLAMEL TECHNOLOGIES SA	875,000	$15,733	3.3%	$17.98	—	SPONSORED ADR	338488109
—	APRICUS BIOSCIENCES INC	6,524,505	$12,201	2.6%	$1.73	—	COM	03832V109
—	REPROS THERAPEUTICS INC	1,132,367	$9,727	2.1%	$16.90	—	COM NEW	76028H209
—	INTRA CELLULAR THERAPIES INC	360,000	$8,597	1.8%	$16.06	—	COM	46116X101
—	VIVUS INC	2,573,943	$6,332	1.3%	$9.08	—	COM	928551100
—	KINDRED BIOSCIENCES INC	689,091	$4,920	1.0%	$11.56	—	COM	494577109
—	AVEO PHARMACEUTICALS INC	2,570,759	$3,728	0.8%	$1.84	—	COM	053588109
ANIP	ANI PHARMACEUTICALS INC	31,000	$1,939	0.4%	$44.09	+38.0%	COM	00182C103
—	TARGACEPT INC	630,000	$1,871	0.4%	$4.63	—	COM	87611R306
—	ELEVEN BIOTHERAPEUTICS INC.	41,200	$368	0.1%	$11.87	—	COM	286221106